India atorvastatin market is expected to grow at a steady rate during the forecast period. The India atorvastatin market is driven by the surging use of this class of drugs for treating cardiovascular diseases in the country such as atherosclerosis, heart attack, angina, stroke, etc. In addition to this, it is used as protective agent for myocardial infarction, revascularization in patients with type 2 diabetes without coronary heart disease but with multiple risk factors. Along with this, supportive government policies and schemes for promoting the development of drugs, intermediates and active pharmaceutical ingredients in the country are further anticipated to bode well for the market growth.
The India atorvastatin market is segmented based on source, form, distribution channel, application, company and region. Based on application, the market can be split into hypercholesterolemia, hypertriglyceridemia, dyslipidaemia and others. The hypercholesterolemia is expected to dominate the market owing to rising incidence of hypercholesterolemia in the country. Based on distribution channel, the market is split into online v/s offline. Out of which, the online segment is also expected to register significant growth over the next few years. This can be ascribed to the emergence of several online pharmacies and doorstep drug delivery e-commerce platforms in the country.
The major players operating in the India atorvastatin market are Jubilant Life Sciences Ltd., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Ind-Swift Labs Ltd., Morepen Laboratories Ltd., Anuh Pharma Ltd., Cadila Pharmaceuticals Ltd., Pfizer Limited, Teva API India Limited, Lupin Limited and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. For Instance, the U.S. FDA granted license to Morepen Laboratories to manufacture atorvastatin calcium for export to the U.S., thus strengthening the market position.
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India atorvastatin market from FY2016 to FY2019.
- To estimate and forecast the market size of India atorvastatin market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India atorvastatin market based on source, form, distribution channel, application, company and regional distribution.
- To identify dominant region or segment in the India atorvastatin market.
- To identify drivers and challenges for India atorvastatin market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India atorvastatin market.
- To identify and analyze the profile of leading players operating in India atorvastatin market.
- To identify key sustainable strategies adopted by market players in India atorvastatin market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Atorvastatin manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to atorvastatin
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
